Use of G-CSF alone to mobilize peripheral blood stem cells for collection from children

Br J Haematol. 1994 Nov;88(3):633-5. doi: 10.1111/j.1365-2141.1994.tb05088.x.

Abstract

We report the data of 19 children with neuroblastoma (NB) or Ewing's sarcoma (EW) who had peripheral blood stem cells (PBSCs) harvested after mobilization by: (1) cyclophosphamide (CY) + etoposide + G-CSF, (2) CY + GM-CSF, or (3) G-CSF alone. There were no consistent differences in the number of PBSCs collected following these three different mobilization regimens as assessed by CFU-GM. 17 patients were reinfused with PBSCs after myeloablative therapy and had successful haemopoietic recovery. These results show that in children with solid tumours such as NB or EW a sufficient number of PBSCs can be collected after G-CSF alone, and that PBSCs collected following stimulation by G-CSF alone are as effective in reconstituting haemopoiesis as those collected after mobilizing chemotherapy + HGFs.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Child, Preschool
  • Cyclophosphamide / therapeutic use
  • Erythroid Precursor Cells / physiology*
  • Etoposide / therapeutic use
  • Granulocyte Colony-Stimulating Factor / pharmacology*
  • Hematopoietic Stem Cell Transplantation*
  • Humans
  • Infant, Newborn
  • Neuroblastoma / therapy
  • Sarcoma, Ewing / therapy

Substances

  • Granulocyte Colony-Stimulating Factor
  • Etoposide
  • Cyclophosphamide